A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint pain and inflammation. The condition is chronic, and there’s no cure. However, in recent years, new treatment options have ...

Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

DelveInsight's Rheumatoid Arthritis Pipeline report depicts a robust space with 75+ active players working to develop 80+ ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a ...